Copyright
©2005 Baishideng Publishing Group Inc.
World J Gastroenterol. Jan 28, 2005; 11(4): 469-475
Published online Jan 28, 2005. doi: 10.3748/wjg.v11.i4.469
Published online Jan 28, 2005. doi: 10.3748/wjg.v11.i4.469
Table 1 Genotype specific capture probes (Aminolink1) and competitive oligonucleotide probes.
Probe name | Sequences | Use |
MH1Ami | 5'-Aminolink-tttttgctcaatgcctggagatttg-3' | Genotype 1 specific capture probe |
MHCG1C | 5'-cactctatgcccggcc-3' | Competitor oligonucleotide to genotype 2 |
MHCG1C3 | 5'-tcaatrcccraaatttg-3' | Competitor oligonucleotide to genotype 3 |
MH2Ami | 5'- Aminolink-tttttcttggataaacccactctatgyc-3' | Genotype 2 specific capture probe |
MHCG2C | 5'-ggatcaacccgctcaatg-3' | Competitive oligonucleotide to genotype 1 |
MHCG2C3 | 5'-arcaacccgctcaatg-3' | Competitive oligonucleotide to genotype 3 |
MH3Ami | 5'- Aminolink-tttttgaatcgctggggtgaccg-3' | Genotype 3 specific capture probe |
MH3’Ami | 5'- Aminolink-tttttcgcgagatcactagccgagtag-3' | Genotype 3 specific capture probe |
MHCG3C | 5'-aattgccrggamgac-3' | Competitive oligonucleotide to genotype 1, 2 |
MHCG3’C | 5'-cgcragactgctagccga-3' | Competitive oligonucleotide to genotype 1, 2 |
Table 2 Universal biotin-labeled HCV specific probes for the amplification of the detection signal.
Probe name | Sequences |
MH211B+ | 5'-Biotin-ctagccgagtagcgttgggttgcgaaagg-3' |
MH111B+ | 5'-Biotin-ctagccgagtagtgttgggtcgcgaaagg-3' |
MHBT1 | 5'-Biotin-tagtatgagtgtcgtgcagcctccaggc-3' |
MHBT2 | 5'-Biotin-gagagccatagtggtctgcggaaccggt-3' |
MHBT3 | 5'-Biotin-gagtacaccggaattgccaggacgacc-3' |
MHBT4 | 5'-Biotin ccttgtggtactgcctgatagggtgcttg-3' |
Table 3 Detection limit of the HCV Guideline test in 264 samples infected with HCV.
Amplicor monitor | Number (IU/mL) | HCV-Guideline positivity, n (%) |
<500 | 12 | 0 (0) |
500-1000 | 18 | 18 (100.0) |
1000-10000 | 73 | 73 (100.0) |
10000-100000 | 71 | 71 (100.0) |
100000-850000 | 62 | 62 (100.0) |
850000< | 28 | 28 (100.0) |
Table 4 HCV genotypes of 252 serum samples from patients with chronic HCV infection as determined by HCV-Guideline test and a core genotyping method reported by Ohno and colleagues[19].
Core genotyping | HCV-Guideline test | |||||
1 | 2 | 3 | 1+2 | 1+3 | Total | |
1a | 1 | 0 | 0 | 0 | 0 | 1 |
1b | 147 | 0 | 0 | 0 | 0 | 147 |
2a | 0 | 64 | 0 | 0 | 0 | 64 |
2b | 0 | 15 | 0 | 0 | 0 | 15 |
3a | 0 | 0 | 13 | 0 | 0 | 13 |
3b | 0 | 0 | 1 | 0 | 0 | 1 |
2a+2b | 0 | 2 | 0 | 0 | 0 | 2 |
1b+2a | 2 | 1 | 0 | 0 | 0 | 3 |
1b+2b | 0 | 0 | 0 | 1 | 0 | 1 |
1b+3a | 0 | 0 | 1 | 0 | 1 | 2 |
Not classified | 0 | 3 | 0 | 0 | 0 | 3 |
Total | 150 | 85 | 15 | 1 | 1 | 252 |
Table 5 HCV genotypes and serotypes of 252 serum samples from patients with chronic HCV infection as determined by HCV-Guideline test and serological Immucheck HCV GR test.
Serotyping | HCV-Guideline test | |||||
1 | 2 | 3 | 1+2 | 1+3 | Total | |
G1 | 142 | 0 | 0 | 0 | 1 | 143 |
G2 | 11 | 76 | 0 | 0 | 0 | 77 |
Not determined | 7 | 9 | 15 | 1 | 0 | 32 |
Total | 150 | 85 | 15 | 1 | 1 | 252 |
- Citation: Mukaide M, Tanaka Y, Kakuda H, Fujiwara K, Kurbanov F, Orito E, Yoshioka K, Fujise K, Harada S, Kozaki T, Takemura K, Hikiji K, Mizokami M. New combination test for hepatitis C virus genotype and viral load determination using Amplicor GT HCV MONITOR test v2.0. World J Gastroenterol 2005; 11(4): 469-475
- URL: https://www.wjgnet.com/1007-9327/full/v11/i4/469.htm
- DOI: https://dx.doi.org/10.3748/wjg.v11.i4.469